Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04009512 · ClinicalTrials.gov registry record · NA
Endovascular Repair of Thoracoabdominal Aortic Aneurysms
A NA study of Thoracoabdominal Aortic Aneurysm, sponsored by Matthew Eagleton.
- Active
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT04009512: Active NA study of Thoracoabdominal Aortic Aneurysm, sponsored by Matthew Eagleton.
NCT04009512 is a NA study of Thoracoabdominal Aortic Aneurysm that is active but no longer recruiting, run by Matthew Eagleton. The registered enrollment target is 15 participants, below the 199-participant average among 11 other Thoracoabdominal Aortic Aneurysm trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04009512, a NA study of Thoracoabdominal Aortic Aneurysm, is active but no longer recruiting, sponsored by Matthew Eagleton.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to assess the use of the thoracic bifurcation and the visceral manifold devices in the repair thoracoabdominal aortic aneurysms in patients with appropriate anatomy. The primary intent of the study is to assess safety and preliminary effectiveness of the device. Additionally, the study will assess technical success and treatment success at each follow-up interval.
Conditions Studied
Interventions
- DEVICE Valiant Thoracoabdominal Stent Graft System
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-10-06 |
| Est. Completion | 2026-08-26 |
| Phase | NA |
What the registry record for NCT04009512 still lists
NCT04009512 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 199-participant average among 11 other Thoracoabdominal Aortic Aneurysm trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Thoracoabdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Valiant Thoracoabdominal Stent Graft System is the first listed.
NCT04009512 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04009512 about?
NCT04009512 is a clinical study titled "Endovascular Repair of Thoracoabdominal Aortic Aneurysms". The primary objective of this study is to assess the use of the thoracic bifurcation and the visceral manifold devices in the repair thoracoabdominal aortic aneurysms in patients with appropriate anatomy. The primary intent of the study is to assess safety and preliminary effectiveness of the device...
What is the current status of trial NCT04009512?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2020-10-06. Estimated completion is 2026-08-26.
What conditions does trial NCT04009512 study?
This clinical trial studies the following conditions: Thoracoabdominal Aortic Aneurysm.
What interventions are being tested in trial NCT04009512?
The interventions under investigation include: Valiant Thoracoabdominal Stent Graft System (DEVICE).
Who is sponsoring clinical trial NCT04009512?
This trial is sponsored by Matthew Eagleton, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04009512 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thoracoabdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04009512's enrollment target sits among peer trials
15 12th of 11 the lowest of 11 other Thoracoabdominal Aortic Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Thoracoabdominal Aortic Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms
RECRUITING · NA
-
CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft
RECRUITING · NA
-
PMEG for Repair of Pararenal and Thoracoabdominal Aortic Aneurysm
RECRUITING · NA
-
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
RECRUITING · NA
-
Clinical Outcomes and Major Adverse Events in Patients Treated With Physician-Modified Fenestrated and Branched Stent Grafts
RECRUITING · NA
-
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI